PAVmed Inc.
PAVM
$0.36
$0.011.98%
NASDAQ
| 09/30/2025 | 06/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -16.67% | -25.00% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -16.67% | -25.00% | |||
| Cost of Revenue | 34.15% | 13.89% | |||
| Gross Profit | -42.86% | -25.00% | |||
| SG&A Expenses | -4.73% | -16.00% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 2.71% | -13.44% | |||
| Operating Income | -2.74% | 13.42% | |||
| Income Before Tax | 51.23% | -166.18% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 51.23% | -166.18% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | 55.83% | 16.81% | |||
| Net Income | 54.84% | -162.85% | |||
| EBIT | -2.74% | 13.42% | |||
| EBITDA | -2.75% | 13.14% | |||
| EPS Basic | 60.10% | -157.71% | |||
| Normalized Basic EPS | 47.40% | 62.76% | |||
| EPS Diluted | 60.32% | -317.65% | |||
| Normalized Diluted EPS | 47.40% | -40.98% | |||
| Average Basic Shares Outstanding | 19.19% | 30.33% | |||
| Average Diluted Shares Outstanding | 19.19% | -65.55% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||